Literature DB >> 17516559

Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapy.

Karl Kieburtz1, C Warren Olanow.   

Abstract

In the past decade, there has been an increasing emphasis on laboratory-based translational research. This has led to significant scientific advances in our understanding of disease mechanisms and in the development of novel approaches to therapy such as gene therapy, RNA interference, and stem cells. However, the translation of these remarkable scientific achievements into new and effective disease-modifying therapies has lagged behind these scientific accomplishments. We use the term "translational experimental therapeutics" to describe the pathway between the discovery of a basic disease mechanism or novel therapeutic approach and its translation into an effective treatment for patients with a specific disease. In this article, we review the components of this pathway, and discuss issues that might impede this process. Only by optimizing this pathway can we realize the full therapeutic potential of current scientific discoveries and translate the astounding advances that have been accomplished in the laboratory into effective treatments for our patients. Copyright (c) 2007 Mount Sinai School of Medicine.

Entities:  

Mesh:

Year:  2007        PMID: 17516559     DOI: 10.1002/msj.20006

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  9 in total

1.  Translational research: current status, challenges and future strategies.

Authors:  Dale Yu
Journal:  Am J Transl Res       Date:  2011-09-12       Impact factor: 4.060

Review 2.  Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  Curr Opin Pharmacol       Date:  2018-03-30       Impact factor: 5.547

3.  Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein.

Authors:  Eduard Bentea; Anke Van der Perren; Joeri Van Liefferinge; Anissa El Arfani; Giulia Albertini; Thomas Demuyser; Ellen Merckx; Yvette Michotte; Ilse Smolders; Veerle Baekelandt; Ann Massie
Journal:  Front Behav Neurosci       Date:  2015-03-31       Impact factor: 3.558

4.  Current animal models of Alzheimer's disease: challenges in translational research.

Authors:  Mar Cuadrado-Tejedor; Ana García-Osta
Journal:  Front Neurol       Date:  2014-09-29       Impact factor: 4.003

5.  Caloric Restriction Protects against Lactacystin-Induced Degeneration of Dopamine Neurons Independent of the Ghrelin Receptor.

Authors:  Jessica Coppens; Eduard Bentea; Jacqueline A Bayliss; Thomas Demuyser; Laura Walrave; Giulia Albertini; Joeri Van Liefferinge; Lauren Deneyer; Najat Aourz; Ann Van Eeckhaut; Jeanelle Portelli; Zane B Andrews; Ann Massie; Dimitri De Bundel; Ilse Smolders
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

6.  Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.

Authors:  Tiffany C Chang; Margarite D Matossian; Steven Elliott; Hope E Burks; Rachel A Sabol; Deniz A Ucar; Henri Wathieu; Jovanny Zabaleta; Luis Del Valle; Sukhmani Gill; Elizabeth Martin; Adam I Riker; Lucio Miele; Bruce A Bunnell; Matthew E Burow; Bridgette M Collins-Burow
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

Review 7.  Systematic reviews of animal models: methodology versus epistemology.

Authors:  Ray Greek; Andre Menache
Journal:  Int J Med Sci       Date:  2013-01-11       Impact factor: 3.738

8.  A review of the Institute of Medicine's analysis of using chimpanzees in biomedical research.

Authors:  Robert C Jones; Ray Greek
Journal:  Sci Eng Ethics       Date:  2013-04-25       Impact factor: 3.525

Review 9.  Roles of Glutamate Receptors in Parkinson's Disease.

Authors:  Zhu Zhang; Shiqing Zhang; Pengfei Fu; Zhang Zhang; Kaili Lin; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.